Given the important roles of both USP22 and AP2 in lung cancer carcinogenesis, our finding of the association between these two proteins further supports USP22 deubiquitinate as a potential biomarker and therapeutic target for lung cancer. The gene discussed is USP22; the disease is lung carcinoma.